Scott Hirsch

Senior Vice President, Business Strategy 

Scott Hirsch joined Valeant in August 2016. He is a seasoned investment professional with a deep knowledge of the specialty pharmaceutical industry. He joined Valeant from Citadel Investment Group, where he oversaw equity investments and risk management decisions within the Health Care sector at Surveyor Capital.  Earlier in his career, he was in the investment banking group of Credit Suisse as the Lead Equity Research Analyst covering Specialty Pharmaceuticals and Generics.